🎓📷 Congratulations to Sarah Bazargan, PhD! Sarah successfully defended her dissertation last week! She looked at how targeting tumor environmental factors in bladder cancer enhance responses with immunotherapy. Sarah was mentored by @spt_lab during her PhD. Well done Sarah!
Another great HIP-IMO program, this year led by @ReneeBradyPhD with 15 amazing presentations, including Eros in collaboration with Guevara lab, Haarika and Jai in collaboration with @spt_lab. Projects co-mentored by @Kay_olumoyin, Maureiq and Ana, #hipimo, @moffittNews
As the voting deadline approaches for the #SITC elections, we wanted to share some more information about our very own Dr. Shari Pilon-Thomas who is nominated for the @sitcancer At-Large Director! Get your votes in now!
Join Oluwaseyi Oluwatola of @spt_lab at #AAI2024 as she presents on the functional role of KLRG1+ Tregs in non-small cell lung cancer. #NSCLC
⏰ 5/4 8:00 - 8:15 a.m. CT
📍W178
@ImmunologyAAI
Congratulations to our Shari Pilon-Thomas, PhD, (@spt_lab) for being nominated as a @sitcancer At-Large Director!
Learn more about Shari Pilon-Thomas, PhD and the other candidates by visiting https://t.co/96qIwF9Weu.
The #SITC election starts on Thursday! The three At-Large Directors who receive the plurality of votes will begin three-year terms in 2025. Read the biographies and platform statements of this year’s candidates at https://t.co/GJhZRbZm8d
Sharing my support for @spt_lab who has been a tremendous mentor to me and so many others. She is a prolific collaborator and her work forms the basis of so many clinical trials that have directly impacted patient lives. Go vote! @MoffittNews
After a posting hiatus, we are back and happy to share our excitement over the FDA approval of Tumor-Infiltrating Lymphocytes for the treatment of advanced melanoma!
https://t.co/hRBFz2yY3M
A first-of-its-kind cellular immunotherapy, #TILTherapy, was pioneered at Moffitt Cancer Center and is now available for patients with advanced melanoma. Learn more about TIL and what it means for the future of treating solid tumors: https://t.co/1JS5z9iZkJ
#CancerResearch
Join Moffitt's President and CEO, @PatrickHwuMD, as he shares insights on the recent @FDA approval of a groundbreaking treatment for advanced melanoma. Discover how TIL therapy is revolutionizing cancer treatment. #CancerResearch
APPLY NOW 💻 If chosen, the Moffitt Innovators of Tomorrow (MIOT) Symposium will provide students a complimentary trip to Tampa, Florida to visit our campus, present their research, meet our faculty and learn about our postdoctoral training opportunities. https://t.co/il44TsQcsm